Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReQuip PR as Adjunctive Therapy in Parkinson's Disease
NCT01154166Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2010
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ropinirole in Parkinson's disease (PD), sponsored by GSK. Started Feb 2010; status: completed.
02
Drugs
ropinirole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01154166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01154166.